{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:50:14Z","timestamp":1788814214376,"version":"build-2803163510"},"reference-count":66,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>If the number of viral hepatitis infections is to be decreased worldwide, and the World Health Organization (WHO) elimination targets are to be achieved by 2030, this requires determining the burden of infection according to the WHO\u2019s test-and-treat approach. In 2014, the introduction of Direct-Acting Antivirals (DAAs) revolutionized the management of Hepatitis C Virus (HCV); another improvement came in 2020, when the use of bulevirtide (BLV) was authorized as a treatment for chronic Hepatitis D Virus (HDV) infection, showing good efficacy. The present observational study was carried out between 2019 and 2024. The diagnosis of viral hepatitis was carried out by routine assays. HDV typing was performed by Sanger sequencing and phylogenetic analysis. Overall, the HCV antibody prevalence was 3.4% in the studied time span, and it was higher in males than in females (59% vs. 41%). In viremic patients, HCV1b (33%) and HCV2a\/2c (25%) were the most common subtypes. The overall HCV viremic rate declined in 2022 (2.8%). Unlike HCV, 71.4% of HDV viremic patients were females, and they had a median age of 58 years. The viral load of HDV RNA ranged from 20 IU\/mL to 8 million IU\/mL. Viral genotypes were classified as HDV1c and HDV1e. In this study, we highlight the prevalence of HCV\/HDV infections and their genotype evolution in Southern Italy, underscoring the urgent need to enhance screening and linkage to care. Finally, we quantify the burden of active infections in order to provide data from real-life settings, and we describe the virological status of people living with HCV or HBV\/HDV, who may experience significant benefits in terms of liver-related mortality after DAA or BLV treatment.<\/jats:p>","DOI":"10.3390\/pathogens14090941","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T08:03:47Z","timestamp":1758096227000},"page":"941","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatitis C (HCV) and Hepatitis Delta (HDV) Viruses in a Teaching Hospital in Southern Italy: What Is the Epidemiological Situation in the Era of New Drugs?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0880-8955","authenticated-orcid":false,"given":"Nadia","family":"Marascio","sequence":"first","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7685-3419","authenticated-orcid":false,"given":"Grazia","family":"Pavia","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6446-470X","authenticated-orcid":false,"given":"Chiara","family":"Mazzei","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Manno","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-8084","authenticated-orcid":false,"given":"Giorgio Settimo","family":"Barreca","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Peronace","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Ciurleo","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Trimboli","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pantanella","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-8322","authenticated-orcid":false,"given":"Angelo Giuseppe","family":"Lamberti","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Matera","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Quirino","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"ref_1","unstructured":"(2024, July 13). Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Quirino, A., Marascio, N., Branda, F., Ciccozzi, A., Romano, C., Locci, C., Azzena, I., Pascale, N., Pavia, G., and Matera, G. (2024). Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies. Pathogens, 13.","DOI":"10.3390\/pathogens13090766"},{"key":"ref_3","unstructured":"(2025, June 05). CDC Global Viral Hepatitis, Available online: https:\/\/www.cdc.gov\/hepatitis\/global\/index.html."},{"key":"ref_4","first-page":"561","article-title":"Declining Incidence of Hepatitis C Related Hepatocellular Carcinoma in the Era of Interferon-Free Therapies: A Population-Based Cohort Study","volume":"42","author":"Innes","year":"2022","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2468-1253(23)00335-7","article-title":"Direct-Acting Antiviral Therapies for Hepatitis C Infection: Global Registration, Reimbursement, and Restrictions","volume":"9","author":"Marshall","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S2468-1253(24)00442-4","article-title":"Global, Regional, and National Estimates of Hepatitis C Virus (HCV) Infection Incidence among People Who Inject Drugs and Number of New Annual HCV Infections Attributable to Injecting Drug Use: A Multi-Stage Analysis","volume":"10","author":"Artenie","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Marascio, N., Mazzitelli, M., Pavia, G., Giancotti, A., Barreca, G.S., Costa, C., Pisani, V., Greco, G., Serapide, F., and Trecarichi, E.M. (2019). Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir\/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4. Cells, 8.","DOI":"10.3390\/cells8050416"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Marascio, N., Pavia, G., Strazzulla, A., Dierckx, T., Cuypers, L., Vrancken, B., Barreca, G.S., Mirante, T., Malanga, D., and Oliveira, D.M. (2016). Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Na\u00efve Patients. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091416"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Marascio, N., Costantino, A., Taffon, S., Lo Presti, A., Equestre, M., Bruni, R., Pisani, G., Barreca, G.S., Quirino, A., and Trecarichi, E.M. (2021). Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081655"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1002\/slct.201800649","article-title":"Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Na\u00efve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity","volume":"3","author":"Romeo","year":"2018","journal-title":"ChemistrySelect"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global Change in Hepatitis C Virus Prevalence and Cascade of Care between 2015 and 2020: A Modelling Study","volume":"7","author":"Blach","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hep.510260431","article-title":"Prevalence, Risk Factors, and Genotype Distribution of Hepatitis C Virus Infection in the General Population: A Community-Based Survey in Southern Italy","volume":"26","author":"Guadagnino","year":"1997","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.44.6.874","article-title":"Clinical Course and Risk Factors of Hepatitis C Virus Related Liver Disease in the General Population: Report from the Dionysos Study","volume":"44","author":"Bellentani","year":"1999","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0168-8278(00)80167-1","article-title":"Hepatitis C Virus Infection and Alanine Transaminase Levels in the General Population: A Survey in a Southern Italian Town","volume":"33","author":"Maio","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_15","first-page":"377","article-title":"Financial and Feasibility Implications of the Treatment of Hepatitis C Virus in Italy: Scenarios and Perspectives","volume":"8","author":"Croce","year":"2016","journal-title":"Clin. Outcomes Res. CEOR"},{"key":"ref_16","first-page":"7","article-title":"HCV\u2014Estimation of the Number of Diagnosed Patients Eligible to the New Anti-HCV Therapies in Italy","volume":"20","author":"Gardini","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical Features of Hepatitis D","volume":"32","author":"Farci","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The Global Prevalence of Hepatitis D Virus Infection: Systematic Review and Meta-Analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic Hepatitis D and Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies","volume":"73","author":"Alfaiate","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jhep.2023.10.043","article-title":"Adjusted Estimate of the Prevalence of Hepatitis Delta Virus in 25 Countries and Territories","volume":"80","author":"Child","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_21","first-page":"1","article-title":"Prevalence of Hepatitis D Virus Infection in Central Italy Has Remained Stable across the Last 2 Decades with Dominance of Subgenotypes 1 and Characterized by Elevated Viral Replication","volume":"138","author":"Salpini","year":"2024","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jvh.13310","article-title":"Migratory Flow and Hepatitis Delta Infection in Italy: A New Challenge at the Beginning of the Third Millennium","volume":"27","author":"Stroffolini","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_23","first-page":"438","article-title":"The Present Profile of Chronic Hepatitis B Virus Infection Highlights Future Challenges: An Analysis of the Multicenter Italian MASTER-B Cohort","volume":"51","author":"Brancaccio","year":"2019","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_24","first-page":"842","article-title":"Clinical and Virological Heterogeneity of Hepatitis Delta in Different Regions World-Wide: The Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke","year":"2018","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100547","DOI":"10.1016\/j.jhepr.2022.100547","article-title":"Implementation of Anti-HDV Reflex Testing among HBsAg-Positive Individuals Increases Testing for Hepatitis D","volume":"4","author":"Palom","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_27","first-page":"148","article-title":"Anti-HDV Reflex Testing in HBsAg-Positive Subjects: An Efficacious Strategy to Identify HDV Infection","volume":"44","author":"Cossiga","year":"2024","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jhep.2024.05.001","article-title":"Bulevirtide Monotherapy in Patients with Chronic HDV: Efficacy and Safety Results through Week 96 from a Phase III Randomized Trial","volume":"81","author":"Wedemeyer","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_29","unstructured":"(2025, June 05). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021. Towards Ending Viral Hepatitis. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10198-023-01652-0","article-title":"Screening Strategy to Advance HCV Elimination in Italy: A Cost-Consequence Analysis","volume":"25","author":"Marcellusi","year":"2024","journal-title":"Eur. J. Health Econ. HEPAC Health Econ. Prev. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2025.01.013","article-title":"Number of People Treated for Hepatitis C Virus Infection in 2014\u20132023 and Applicable Lessons for New HBV and HDV Therapies","volume":"83","author":"Razavi","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Salpini, R., Svicher, V., and Kennedy, P.T. (2023). Editorial: The Current Challenges Underlying Hepatitis D Virus Infection. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1355027"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jvh.13086","article-title":"Genetic Diversity of Hepatitis D Virus Genotype-1 in Europe Allows Classification into Subtypes","volume":"26","author":"Karimzadeh","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_36","unstructured":"(2025, June 30). FigTree. Available online: http:\/\/tree.bio.ed.ac.uk\/software\/figtree\/."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/1874285802014010084","article-title":"HCV Antibody Prevalence and Genotype Evolution in a Teaching Hospital, Calabria Region, Southern Italy Over A Decade (2008\u20132018)","volume":"14","author":"Marascio","year":"2020","journal-title":"Open Microbiol. J."},{"key":"ref_38","unstructured":"Polaris Observatory HCV Collaborators (2017). Global Prevalence and Genotype Distribution of Hepatitis C Virus Infection in 2015: A Modelling Study. Lancet Gastroenterol. Hepatol., 2, 161\u2013176."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Veneziano, C., Marascio, N., De Marco, C., Quaresima, B., Biamonte, F., Trecarichi, E.M., Santamaria, G., Quirino, A., Torella, D., and Quattrone, A. (2023). The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution. Viruses, 15.","DOI":"10.3390\/v15020408"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"De Marco, C., Veneziano, C., Massacci, A., Pallocca, M., Marascio, N., Quirino, A., Barreca, G.S., Giancotti, A., Gallo, L., and Lamberti, A.G. (2022). Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.934993"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e29708","DOI":"10.1002\/jmv.29708","article-title":"Persistence of SARS-CoV-2 Infection and Viral Intra- and Inter- host Evolution in COVID-19 Hospitalized Patients","volume":"96","author":"Pavia","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jvh.13983","article-title":"Hepatitis C Epidemiology and Treatment Outcomes in Italy: Impact of the DAA Era and the COVID-19 Pandemic","volume":"31","author":"Ceccarelli","year":"2024","journal-title":"J. Viral Hepat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12954-024-01115-6","article-title":"How Far Are We? Assessing Progress in Hepatitis C Response towards the WHO 2030 Elimination Goals by the Civil Society Monitoring in 25 European Countries, Period 2020 to 2023","volume":"21","author":"Maticic","year":"2024","journal-title":"Harm. Reduct. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global Epidemiology of Hepatitis C Virus Infection: An up-Date of the Distribution and Circulation of Hepatitis C Virus Genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1136\/gutjnl-2024-332177","article-title":"\u2018Unusual\u2019 HCV Genotype Subtypes: Origin, Distribution, Sensitivity to Direct-Acting Antiviral Drugs and Behaviour on Antiviral Treatment and Retreatment","volume":"73","author":"Pawlotsky","year":"2024","journal-title":"Gut"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL Recommendations on Treatment of Hepatitis C: Final Update of the Series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Malandris, K., Kalopitas, G., Theocharidou, E., and Germanidis, G. (2021). The Role of RASs\/RVs in the Current Management of HCV. Viruses, 13.","DOI":"10.3390\/v13102096"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5501\/wjv.v4.i4.313","article-title":"Hepatitis Delta Virus: A Fascinating and Neglected Pathogen","volume":"4","author":"Cunha","year":"2015","journal-title":"World J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0168-8278(97)80004-9","article-title":"Decrease in HDV Endemicity in Italy","volume":"26","author":"Sagnelli","year":"1997","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Caviglia, G.P., Ciancio, A., and Rizzetto, M. (2022). A Review of HDV Infection. Viruses, 14.","DOI":"10.3390\/v14081749"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/524074","article-title":"Chronic Hepatitis B in Italy: New Features of an Old Disease\u2014Approaching the Universal Prevalence of Hepatitis B e Antigen-Negative Cases and the Eradication of Hepatitis D Infection","volume":"46","author":"Sagnelli","year":"2008","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_52","unstructured":"(2025, June 30). EpiCentro Archivio del Bollettino SEIEVA. Available online: https:\/\/www.epicentro.iss.it\/epatite\/dati-seieva-archivio."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"a021576","DOI":"10.1101\/cshperspect.a021576","article-title":"Hepatitis D Virus: Introduction and Epidemiology","volume":"5","author":"Rizzetto","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_54","first-page":"123","article-title":"Epidemiology and Clinical Outcomes of Hepatitis Delta (D) Virus Infection in Queensland, Australia","volume":"74","author":"Coghill","year":"2018","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Sausen, D.G., Shechter, O., Bietsch, W., Shi, Z., Miller, S.M., Gallo, E.S., Dahari, H., and Borenstein, R. (2022). Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415973"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1478-3231.2009.02140.x","article-title":"Quantitative HBsAg and HDV-RNA Levels in Chronic Delta Hepatitis","volume":"30","author":"Zachou","year":"2010","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jvh.13811","article-title":"Bulevirtide-Based Treatment Strategies for Chronic Hepatitis Delta: A Review","volume":"30","author":"Degasperi","year":"2023","journal-title":"J. Viral Hepat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1572-0241.1998.00354.x","article-title":"Clinical and Virological Course of Chronic Hepatitis B Virus Infection with Hepatitis C and D Virus Markers","volume":"93","author":"Liaw","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/jhep.2001.26511","article-title":"Role of Hepatitis B, C, and D Viruses in Dual and Triple Infection: Influence of Viral Genotypes and Hepatitis B Precore and Basal Core Promoter Mutations on Viral Replicative Interference","volume":"34","author":"Jardi","year":"2001","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1423-0410.2010.01426.x","article-title":"Hepatitis B, Hepatitis C and HIV Transfusion-Transmitted Infections in the 21st Century","volume":"100","author":"Dwyre","year":"2011","journal-title":"Vox Sang."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1743-422X-8-368","article-title":"An Overview of Triple Infection with Hepatitis B, C and D Viruses","volume":"8","author":"Riaz","year":"2011","journal-title":"Virol. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jvh.13738","article-title":"Safety Analysis of Glecaprevir\/Pibrentasvir in Patients with Markers of Advanced Liver Disease in Clinical and Real-World Cohorts","volume":"29","author":"Feld","year":"2022","journal-title":"J. Viral Hepat."},{"key":"ref_63","first-page":"223","article-title":"Risk Factors for Hepatitis B and C among Healthy Population: A Community-Based Survey from Four Districts of Southern Italy","volume":"28","author":"Serraino","year":"2020","journal-title":"Infez. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.23736\/S0026-4806.21.07280-3","article-title":"Changing Epidemiology of Hepatitis C in Italy: A Population-Based Survey in a Historically High Endemic Area","volume":"114","author":"Spada","year":"2023","journal-title":"Minerva Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","article-title":"Clinical Outcomes Following DAA Therapy in Patients with HCV-Related Cirrhosis Depend on Disease Severity","volume":"74","author":"Krassenburg","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_66","unstructured":"(2025, July 29). CDC Viral Hepatitis, Available online: https:\/\/www.cdc.gov\/immigrant-refugee-health\/hcp\/domestic-guidance\/viral-hepatitis.html."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/9\/941\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:52Z","timestamp":1760035612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/9\/941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["pathogens14090941"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14090941","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}